Ocugen Stock Quote Today


USD 2.42  0.15  6.61%   

Market Performance
0 of 100
Odds Of Distress
Less than 5
Ocugen is selling for 2.42 as of the 1st of July 2022. This is a 6.61% increase since the beginning of the trading day. The stock's open price was 2.27. Ocugen has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. Equity ratings for Ocugen Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of May 2022 and ending today, the 1st of July 2022. Click here to learn more.
Fiscal Year End
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
3rd of December 2014
Health Care
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company has 215.66 M outstanding shares of which 59.72 M shares are now shorted by private and institutional investors with about 8.27 trading days to cover. More on Ocugen Inc

Moving together with Ocugen

0.93MRNAModerna Potential GrowthPairCorr
0.75JPMJP Morgan Chase Earnings Call  Next WeekPairCorr
0.86DISWalt Disney Fiscal Year End 9th of November 2022 PairCorr

Ocugen Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Ocugen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ocugen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Ocugen Inc generated a negative expected return over the last 90 days
Ocugen Inc has high historical volatility and very poor performance
Net Loss for the year was (69.31 M) with loss before overhead, payroll, taxes, and interest of (33.06 M).
Ocugen Inc currently holds about 129.77 M in cash with (57.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Latest headline from seekingalpha.com: Ocugen, Bharat Biotech COVID vaccine shows better safetyefficacy in kids vs adults - Seeking Alpha
Average Analyst Recommendation
Analysts covering Ocugen report their recommendations after researching Ocugen's financial statements, talking to executives and customers, or listening in on Ocugen's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Ocugen Inc. The Ocugen consensus assessment is calculated by taking the average forecast from all of the analysts covering Ocugen.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Ocugen's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong HoldOvervalued
Ocugen Inc (OCGN) is traded on NASDAQ Exchange in USA and employs 56 people. The company currently falls under 'Small-Cap' category with current market capitalization of 591.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ocugen's market, we take the total number of its shares issued and multiply it by Ocugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Ocugen Inc conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 215.66 M outstanding shares of which 59.72 M shares are now shorted by private and institutional investors with about 8.27 trading days to cover. Ocugen Inc currently holds about 129.77 M in cash with (57.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Check Ocugen Probability Of Bankruptcy
Ocugen owns a total of two hundred fifteen million six hundred sixty thousand outstanding shares. 30% of Ocugen Inc outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Ocugen Ownership Details

Ocugen Stock Price Odds Analysis

What are Ocugen's target price odds to finish over the current price? Proceeding from a normal probability distribution, the odds of Ocugen jumping above the current price in 90 days from now is about 52.85%. The Ocugen Inc probability density function shows the probability of Ocugen stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.7134. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ocugen will likely underperform. Additionally, the company has an alpha of 0.1106, implying that it can generate a 0.11 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 2.42HorizonTargetOdds Above 2.42
47.05%90 days
Based on a normal probability distribution, the odds of Ocugen to move above the current price in 90 days from now is about 52.85 (This Ocugen Inc probability density function shows the probability of Ocugen Stock to fall within a particular range of prices over 90 days) .

Ocugen Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Ocugen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ocugen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ocugen's value.
InstituionSecurity TypeTotal SharesValue
State Street CorpCommon Shares29.2 M96.2 M
Blackrock IncCommon Shares12.2 M40.1 M
Warberg Asset Management LlcPut Options34 K5.7 M
Jane Street Group LlcCall Options710.2 K2.3 M
View Ocugen Diagnostics

Ocugen Inc Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Ocugen market risk premium is the additional return an investor will receive from holding Ocugen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ocugen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Ocugen's alpha and beta are two of the key measurements used to evaluate Ocugen's performance over the market, the standard measures of volatility play an important role as well.

Ocugen Stock Against Markets

Picking the right benchmark for Ocugen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Ocugen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Ocugen is critical whether you are bullish or bearish towards Ocugen Inc at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Ocugen without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Holdings Now


Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Investing Ocugen Inc

You need to understand the risk of investing before taking a position in Ocugen. The danger of trading Ocugen Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ocugen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ocugen. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ocugen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please check Your Equity Center. Note that the Ocugen Inc information on this page should be used as a complementary analysis to other Ocugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Ocugen Stock analysis

When running Ocugen Inc price analysis, check to measure Ocugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocugen is operating at the current time. Most of Ocugen's value examination focuses on studying past and present price action to predict the probability of Ocugen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Ocugen's price. Additionally, you may evaluate how the addition of Ocugen to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Ocugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
548 M
Return On Assets
Return On Equity
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine Ocugen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.